Display Settings:

Format

Send to:

Choose Destination

    Folia Psychiatr Neurol Jpn. 1983;37(2):137-44.

    Metabolism of D-phenylalanine and its effects on concentrations of brain monoamines and amino acids in rats--a basic study on possibility of clinical use of D-phenylalanine as an antidepressant.

    Hashimoto H, Nakajima T, Nishimura T, Kudo Y, Takeda Y, Nakao M, Kanaya H, Horiguchi Y.

    The effect of D-phenylalanine on the concentrations of brain catecholamines, serotonin, beta-phenylethylamine and amino acids was examined using rats injected intraperitoneally with 200 mg/kg of D-phenylalanine. The contents of these monoamines in the rat brain were not affected by the administration of D-phenylalanine. No spectacular change was observed in the concentrations of brain amino acids except phenylalanine, which increased about four times during 30-60 minutes after the injection. This increase was attributed to the administered D-phenylalanine. To confirm the finding that D-phenylalanine did not affect the content of beta-phenylethylamine, the metabolism of D-phenylalanine was examined using D-[14C]-phenylalanine. It was proven that D-phenylalanine did not convert to beta-phenylethylamine. On the basis of these findings the antidepressant effect of D-phenylalanine was critically discussed.

    PMID: 6671633 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Patient drug information